You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
|
|---|---|
| Published in |
Frontiers in oncology, May 2019
|
| DOI | 10.3389/fonc.2019.00417 |
| Pubmed ID | |
| Authors |
Danielle Golub, Nishanth Iyengar, Siddhant Dogra, Taylor Wong, Devin Bready, Karen Tang, Aram S. Modrek, Dimitris G. Placantonakis |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 57% |
| Colombia | 1 | 7% |
| Switzerland | 1 | 7% |
| Japan | 1 | 7% |
| Unknown | 3 | 21% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 79% |
| Practitioners (doctors, other healthcare professionals) | 2 | 14% |
| Scientists | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 194 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 28 | 14% |
| Researcher | 27 | 14% |
| Student > Doctoral Student | 18 | 9% |
| Student > Bachelor | 17 | 9% |
| Student > Master | 11 | 6% |
| Other | 20 | 10% |
| Unknown | 73 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 36 | 19% |
| Medicine and Dentistry | 32 | 16% |
| Chemistry | 9 | 5% |
| Agricultural and Biological Sciences | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Other | 22 | 11% |
| Unknown | 79 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2019.
All research outputs
#1,791,687
of 25,385,509 outputs
Outputs from Frontiers in oncology
#356
of 22,432 outputs
Outputs of similar age
#38,964
of 365,305 outputs
Outputs of similar age from Frontiers in oncology
#11
of 295 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,432 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,305 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 295 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.